Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Cambrex
organization3 mentionslast seen Oct 30, 2026
Contract manufacturer investing in API manufacturing and peptide capabilities.
Relationships 8
- CambrexemploysClaudio Russolo99% confidence2 sources
- Cambrexdevelopssmall molecule active pharmaceutical ingredient99% confidence2 sources
- Cambrexdevelopssynthetic peptide99% confidence2 sources
- Cambrexcommercializessmall molecule active pharmaceutical ingredient95% confidence1 source
- Cambrexcommercializessynthetic peptide95% confidence1 source
- Cambrexdevelopspeptide synthesis80% confidence1 source
- Cambrexdevelopsbiocatalysis80% confidence1 source
- Cambrexdevelopscontinuous flow80% confidence1 source
Relationship
Cambrexdevelopssynthetic peptide
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireOct 30, 2026Cambrex Breaks Ground on $120 Million Expansion in Charles City, Iowa
supporting the development and commercial manufacturing of small molecule active pharmaceutical ingredients (APIs) and synthetic peptides
- newsPR NewswireOct 30, 2026Cambrex Breaks Ground on $120 Million Expansion in Charles City, Iowa
development and commercial manufacturing of small molecule active pharmaceutical ingredients (APIs) and synthetic peptides